Page 4 - Sara Hurvitz News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Patient Profile 3: Metastatic HER2+ BC

Patient Profile 3: Metastatic HER2+ BC
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

United statesHeather mcarthurMelindal telliSara hurvitz

Patient Profile 1: Early Stage HER2+/HR+ BC

Patient Profile 1: Early Stage HER2+/HR+ BC
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

United statesSara hurvitzHeather mcarthur

Typical Approaches for Treatment Selection in the Third Line and Beyond

Typical Approaches for Treatment Selection in the Third Line and Beyond
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

United statesMelindal telliSara hurvitzHeather mcarthur

T-DXd: Updated Results from the DESTINY-Breast Studies and Practical Considerations for Followup

T-DXd: Updated Results from the DESTINY-Breast Studies and Practical Considerations for Followup
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

United statesSara hurvitzHeather mcarthurIan kropMelindal telli

HER2+ mBC: Emerging Agents in the Third-Line and Higher Setting

Debu Tripathy, MD, discusses novel therapies being developed for later-line treatment of HER2+ mBC.

San antonioUnited statesSara hurvitzBreast cancerHer2 breast cancerHer2 positive breast cancerMetastatic breast cancerThird line therapyAntibody drug conjugatesBispecific antibodyI spy trialTulip trialPatina trialJcdk4 6 inhibitorMaintenance therapyHer2 cart cell therapy